Medtronic (MDT) Cash from Investing Activities (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -69.29% |
| Oct 24, 2025 | 32.96% |
| Jul 25, 2025 | -46.73% |
| Apr 25, 2025 | 41.87% |
| Jan 24, 2025 | -144.35% |
| Oct 25, 2024 | -33.20% |
| Jul 26, 2024 | 62.79% |
| Apr 26, 2024 | 1.56% |
| Jan 26, 2024 | -66.75% |
| Oct 27, 2023 | 21.34% |
| Jul 28, 2023 | -13.47% |
| Apr 28, 2023 | -65.51% |
| Jan 27, 2023 | 74.96% |
| Oct 28, 2022 | 27.70% |
| Jul 29, 2022 | -684.87% |
| Apr 29, 2022 | 162.01% |
| Jan 28, 2022 | 38.36% |
| Oct 29, 2021 | 9.57% |
| Jul 30, 2021 | -140.85% |
| Apr 30, 2021 | 169.20% |
| Jan 29, 2021 | -37.28% |
| Oct 30, 2020 | -25,350.00% |
| Jul 31, 2020 | -97.81% |
| Apr 24, 2020 | 120.27% |
| Jan 24, 2020 | -48.11% |
| Oct 25, 2019 | -120.69% |
| Jul 26, 2019 | -4.16% |
| Apr 26, 2019 | 47.57% |
| Jan 25, 2019 | -933.88% |
| Oct 26, 2018 | -81.18% |
| Jul 27, 2018 | 479.28% |
| Apr 27, 2018 | 129.37% |
| Jan 26, 2018 | -106.26% |
| Oct 27, 2017 | 7,179.52% |
| Jul 28, 2017 | 130.51% |
| Apr 28, 2017 | 71.13% |
| Jan 27, 2017 | -1,190.41% |
| Oct 28, 2016 | 74.30% |
| Jul 29, 2016 | -106.21% |
| Apr 29, 2016 | 1,900.39% |
| Jan 29, 2016 | 76.65% |
| Oct 30, 2015 | -10.34% |
| Jul 31, 2015 | 93.52% |
| Apr 24, 2015 | -2,105.07% |
| Jan 23, 2015 | 39.84% |
| Oct 24, 2014 | -19,016.67% |